Table.
Potential indication | Preclinical data |
Non- randomized trials |
Randomized controlled trials |
---|---|---|---|
Enhancing insulin signaling | |||
Type 1 Diabetes mellitus | ✓ | ✓ | |
Type 2 Diabetes mellitus | ✓ | ✓ | |
Type A Insulin Resistance | ✓ | ✓ | |
Rabson Mendenhall Syndrome | ✓ | ✓ | |
Lipodystrophy | ✓ | ✓ | |
Diseases of the Central Nervous System | |||
Dementia | ✓ | ||
Hearing loss | ✓ | ||
Spinal cord injury | ✓ | ||
Cardiovascular disease | ✓ | ||
Osteoporosis | ✓ | ✓ |